Sloveniaelivity®, a Singapore-based longevity supplement brand, has launched NANOBOOST, a new absorption technology designed to enhance the efficiency of oral supplements. Developed in partnership with a German biotech firm derived from Hamburg University, NANOBOOST utilizes advanced liposomal science to improve the delivery of active compounds. This technology creates ultra-fine delivery vehicles such as liposomes, nanoemulsions, and micelles, which protect the compounds during absorption and facilitate their entry into the bloodstream via the mucosal tissue under the tongue. Unlike traditional oral supplements that pass through the gastrointestinal tract, elivity®'s oral sprays bypass this system, reducing exposure to enzymes and pH fluctuations that can degrade sensitive ingredients. The technology aims to increase bioavailability by ensuring more of the active compounds reach systemic circulation.
Bias read (Center): The article discusses a technological advancement in supplement delivery methods without any political commentary, framing, or bias. It focuses solely on the scientific and technical aspects of the product and does not involve political figures, policies, or contentious issues.
Why factuality: no official source document/info detected
Why objectivity (70): The article presents the introduction of NANOBOOST as a significant advancement in supplement absorption technology, using promotional language such as 'patent-pending' and 'first technology of its class.' While informative, the tone leans slightly toward promoting the product, suggesting a commerci
